Algernon Pharma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Algernon Pharma. Real-time updates on events, politics, business and more.

Algernon Pharmaceuticals Inc considers potential spin-off of its NP-120 (Ifenprodil) chronic cough research program

June 27, 2023

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has said it is considering the potential spin-off of its NP-120 (Ifenprodil) chronic cough research...

Christopherj Moreau Algernon Pharma Jacky Smith Peter Dicpinigaitis Algernon Pharmaceuticals Inc Maxim Group

Source: proactiveinvestors.com

Biotech Co. Set To Reach New Highs

April 14, 2023

Biotech Co. Set To Reach New Highs

United States Christopher Bryan Algernon Pharma Christopherj Moreau Ahmad Khalil Amanda Duvall

Source: investorideas.com

Algernon Pharmaceuticals Inc says wholly-owned subsidiary's Reg A+ offering gets US SEC qualification

April 3, 2023

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its wholly-owned subsidiary, Algernon NeuroScience (AGN Neuro), has qualified its Form 1-A...

Algernon Pharma Christopherj Moreau Issuance Inc Algernon Pharmaceuticals Inc Dalmore Group Exchange Commission

Source: proactiveinvestors.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Algernon Pharma News Today

Algernon Pharmaceuticals Inc considers potential spin-off of its NP-120 (Ifenprodil) chronic cough research program

Biotech Co. Set To Reach New Highs

Algernon Pharmaceuticals Inc says wholly-owned subsidiary's Reg A+ offering gets US SEC qualification

Explore More Categories